531 related articles for article (PubMed ID: 28887660)
1. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Badr AMM; Farag Y; Abdelshafy M; Riad NM
Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity.
Yang X; Gao Y; Wang H; Zhao X; Gong X; Wang Q; Zhang X
J Rheumatol; 2014 Sep; 41(9):1793-800. PubMed ID: 25086075
[TBL] [Abstract][Full Text] [Related]
3. Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Hassan W; Behiry E; Mahgoub M
Arch Rheumatol; 2021 Mar; 36(1):47-55. PubMed ID: 34046568
[TBL] [Abstract][Full Text] [Related]
4. Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients.
Mosaad NA; Lotfy HM; Farag YM; Mahfouz RH; Shahin RM
Immunol Lett; 2017 Jan; 181():16-19. PubMed ID: 27838471
[TBL] [Abstract][Full Text] [Related]
5. A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis.
Cai Z; Zhang S; Wu P; Ren Q; Wei P; Hong M; Feng Y; Wong CK; Tang H; Zeng H
Clin Transl Med; 2021 Feb; 11(2):e309. PubMed ID: 33634995
[TBL] [Abstract][Full Text] [Related]
6. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
7. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus.
Watson L; Midgley A; Pilkington C; Tullus K; Marks S; Holt R; Jones C; Beresford M
Lupus; 2012 Apr; 21(5):496-501. PubMed ID: 22147846
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
Sato JO; Corrente JE; Saad-Magalhães C
Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
11. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
[TBL] [Abstract][Full Text] [Related]
12. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
13. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.
Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933
[TBL] [Abstract][Full Text] [Related]
14. Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis.
Hassan AM; Farghal NMA; Hegab DS; Mohamed WS; Abd-Elnabi HH
Clin Rheumatol; 2018 Nov; 37(11):3025-3032. PubMed ID: 30006918
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
16. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
17. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
[TBL] [Abstract][Full Text] [Related]
18. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
Yonsei Med J; 2018 Sep; 59(7):857-864. PubMed ID: 30091319
[TBL] [Abstract][Full Text] [Related]
19. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
[TBL] [Abstract][Full Text] [Related]
20. Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.
Aggarwal A; Gupta R; Negi VS; Rajasekhar L; Misra R; Singh P; Chaturvedi V; Sinha S
Clin Exp Immunol; 2017 May; 188(2):254-262. PubMed ID: 28120479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
